Close
ACHEMA MIDDLE EAST 2026

Deep Dive Into The Pharmaceutical Fine Chemicals Market

The pharmaceutical fine chemicals market is all set to showcase significant growth, with an increase from $136 billion in 2024 to an expected $233...

Fine & Speciality Chemicals World at Chemspec Europe 2024

If you are looking to connect with a spectrum of fine as well as specialty chemicals, you ought to be at Chemspec Europe 2024. We...

Study Suggests Consistent Rise In Pharma Chemicals Market

It is worth noting that the pharmaceutical chemicals market happens to be segmented by Type which includes Reagents, Catalysts, Solvents, KSMs and intermediates, Building...

Key Trends In European Active Pharma Ingredients Market

As per one of the recently held studies in 2024, the Europe Active Pharmaceutical Ingredients- API market size happened to be anticipated at $45.43...

Europe API Market To Reach $80bn By 2033 – Study Predicts

The active pharma ingredient market in Europe has been a matter of much discussion, and no wonder it has laid a very exclusive but...

Research Leads To Major Advancements In Chemical Synthesis

Austria’s University of Vienna’s team of chemists, which happen to be led by Nuno Maulide, has gone on to achieve quite a prominent breakthrough...

$1.5bn Manufacturing Plant By AstraZeneca In Singapore Soon

On May 20, 2024, AstraZeneca, the global biopharma company, announced plans to build a $1.5 billion manufacturing facility in Singapore. With this announcement, the...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...